数字外展干预改善他汀低依从者续药:ADHERE-ASCVD随机临床试验
该研究在Kaiser Permanente Northern California系统内开展实用性随机临床试验,纳入20 604例有他汀适应症且近期不依从的成人,评估自适应序贯数字外展策略对14天他汀续药的影响。结果显示初始数字外展较常规沟通提高续药率(14.4% vs 12.0%;校正风险差2.3个百分点[95%CI 1.3-3.4]),初治无应答者接受二次外展进一步获益,但更换沟通模式未优于重复同一模式。
要点
- 初始数字外展较常规沟通提高14天他汀续药率2.3个百分点。
- 初治无应答者接受二次外展可进一步增加续药率2.5个百分点。
- 更换沟通模式与重复同一模式相比未见额外获益。
核心结论
- 在近期他汀不依从的成人中,自适应序贯数字外展较常规沟通改善短期续药。
- 二次外展对初治无应答者产生额外获益,但更换沟通模式无额外获益。
研究设计与样本
- 实用性、健康系统嵌入式、前瞻性随机开放盲终点(PROBE)临床试验,采用两阶段序贯多重分配随机试验(SMART)设计。
- 通过Kaiser Permanente Northern California开展,纳入20 604例18岁以上、有确诊ASCVD或高ASCVD风险、近期他汀不依从且符合所有沟通方式条件的成人。
主要发现
- 初始数字外展较常规沟通提高14天他汀续药率(14.4% vs 12.0%;校正风险差2.3个百分点[95%CI 1.3-3.4];校正风险比1.20[95%CI 1.10-1.30])。
- 初治无应答者中,二次外展较常规沟通提高续药率(13.0% vs 10.4%;校正风险差2.5个百分点[95%CI 1.3-3.7];校正风险比1.25[95%CI 1.11-1.39])。
- 更换沟通模式与重复同一模式相比,续药率无显著差异(13.2% vs 12.5%;校正风险比1.06[95%CI 0.94-1.17])。
- 28天累积他汀续药率在任一数字外展组高于常规沟通组(24.9% vs 21.2%;校正风险比1.21[95%CI 1.13-1.30])。
临床怎么用
- 可将自适应序贯数字外展整合入人群健康项目,以改善心血管预防中的他汀续药。
- 对初始外展无应答者,可重复同一沟通模式进行二次外展,无需常规更换模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Statin nonadherence is a leading, addressable driver of preventable cardiovascular events. Although health systems routinely use outreach to promote preventive care, most strategies are static and lack evidence from randomized clinical trials. OBJECTIVE: To determine whether an adaptive, sequential digital outreach strategy improves short-term statin refill vs usual communication among adults with established atherosclerotic cardiovascular disease (ASCVD) or high ASCVD risk and recent nonadherence within a rapidly implemented, health system-embedded randomized clinical trial. DESIGN, SETTING, AND PARTICIPANTS: Pragmatic, health system-embedded, prospective randomized open blinded end point (PROBE) clinical trial using a 2-stage sequential, multiple assignment, randomized trial (SMART) design. The trial was conducted via Kaiser Permanente Northern California, an integrated health care delivery system serving more than 4.6 million members. Eligible participants were adults 18 years or older with established ASCVD or high ASCVD risk, recent statin nonadherence, and eligibility for all study communication modalities. INTERVENTIONS: Participants were randomized 1:1:1:1 to receive secure portal messaging, SMS/text messaging, nonsecure email, or usual communication. Initial nonresponders within 14 days underwent prespecified second-stage randomization to repeat the same outreach, switch communication modality, or receive usual communication. MAIN OUTCOMES AND MEASURES: Rates of 14-day statin refill following each randomization, with 28-day follow-up. RESULTS: Among 20 604 participants (mean [SD] age, 54.8 [9.0] years; 40.9% female; 27.8% Asian, 10.9% Black, 33.6% Hispanic; 15.3% with established ASCVD), initial digital outreach increased 14-day statin refill vs usual communication (14.4% vs 12.0%; adjusted risk difference, 2.3 percentage points [95% CI, 1.3-3.4]; adjusted risk ratio, 1.20 [95% CI, 1.10-1.30]). Among initial nonresponders, second-stage outreach further increased refill (13.0% vs 10.4%; adjusted risk difference, 2.5 percentage points [95% CI, 1.3-3.7]; adjusted risk ratio, 1.25 [95% CI, 1.11-1.39]). Switching communication modalities did not improve refill vs repeating the same modality (13.2% vs 12.5%; adjusted risk ratio, 1.06 [95% CI, 0.94-1.17]). Cumulative statin refill through 28 days was higher in those receiving any digital outreach vs usual communication (24.9% vs 21.2%; adjusted hazard ratio, 1.21 [95% CI, 1.13-1.30]). Results were consistent across prespecified subgroups. CONCLUSIONS AND RELEVANCE: Among adults with a statin indication and recent statin nonadherence, adaptive outreach improved short-term refill vs usual communication. A second outreach produced additional gains among initial nonresponders, although switching communication modalities provided no additional benefit. These findings support adaptive, sequential health system outreach strategies to improve cardiovascular prevention when integrated into population health programs. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT07522645.
引用
- Bhatt AS, Liu VX, Sun B, et al. Digital Outreach to Improve Statin Refills in Patients With Low Statin Adherence: The ADHERE-ASCVD Randomized Clinical Trial. JAMA. 2026. PMID: 42667613. doi:10.1001/jama.2026.16372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。